reviewTop 1% cited
Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
Nature Reviews Drug Discovery · 2012 · Vol. 11(8) · pp. 633–652
Charles A. Dinarello✉(University of Colorado Denver)Anna Simon(Radboud University Nijmegen)Jos W.M. van der Meer(Radboud University Medical Center)
Inflammasome and immune disordersIL-33, ST2, and ILC PathwaysAutoimmune and Inflammatory Disorders ResearchAnakinraCanakinumabMedicineImmunologyMonoclonal antibodyInflammationInterleukin 1 receptor antagonistReceptor antagonistCytokinePharmacology
MeSH terms
AnimalsAnti-Inflammatory AgentsAntibodies, MonoclonalAutoimmune DiseasesHumansInflammationInterleukin-1Recombinant Fusion ProteinsSeverity of Illness IndexDrug DesignDrug Delivery SystemsReceptors, Interleukin-1Interleukin 1 Receptor Antagonist ProteinAntibodies, Monoclonal, Humanized
Citations
1,731
FWCI
45.64
field-weighted impact
References
225
Percentile
100%
vs. same field & year
Citations per year
Cited by
Overview of the <scp>IL</scp>‐1 family in innate inflammation and acquired immunity
Immunological Reviews · 2017 · 1,770 citations
The NLRP3 inflammasome: molecular activation and regulation to therapeutics
Nature reviews. Immunology · 2019 · 4,394 citations
Targeting the NLRP3 inflammasome in inflammatory diseases
Nature Reviews Drug Discovery · 2018 · 1,836 citations
Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription
Nature Communications · 2016 · 1,763 citations
The Interleukin-1 Family: Back to the Future
Immunity · 2013 · 1,898 citations
An inflammatory cytokine signature predicts COVID-19 severity and survival
Nature Medicine · 2020 · 2,683 citations
Age and Age-Related Diseases: Role of Inflammation Triggers and Cytokines
Frontiers in Immunology · 2018 · 1,234 citations
Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome
Critical Care Medicine · 2015 · 834 citations
References
Biologic basis for interleukin-1 in disease
Blood · 1996 · 4,341 citations
Inflammation in Atherosclerosis
Journal of the American College of Cardiology · 2009 · 2,133 citations
Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist
Arthritis & Rheumatism · 1998 · 971 citations
Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes
Nature Immunology · 2010 · 1,297 citations
Confirmatory interleukin-1 receptor antagonist trial in severe sepsis
Critical Care Medicine · 1997 · 861 citations
Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)
American Heart Journal · 2011 · 786 citations
The Inflammasomes: Guardians of the Body
Annual Review of Immunology · 2009 · 2,393 citations
NALP3 Forms an IL-1β-Processing Inflammasome with Increased Activity in Muckle-Wells Autoinflammatory Disorder
Immunity · 2004 · 1,736 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.